Compare OVV & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVV | HOLX |
|---|---|---|
| Founded | 2020 | 1985 |
| Country | United States | United States |
| Employees | 1465 | N/A |
| Industry | Oil & Gas Production | Medical Electronics |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 16.9B |
| IPO Year | 2019 | 1995 |
| Metric | OVV | HOLX |
|---|---|---|
| Price | $55.59 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 13 |
| Target Price | $58.35 | ★ $77.89 |
| AVG Volume (30 Days) | 3.6M | ★ 9.6M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | ★ 13.54 | N/A |
| EPS | ★ 4.78 | 0.79 |
| Revenue | ★ $8,908,000,000.00 | $4,100,500,000.00 |
| Revenue This Year | $3.41 | $4.74 |
| Revenue Next Year | N/A | $5.03 |
| P/E Ratio | ★ $11.50 | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $32.16 | $51.90 |
| 52 Week High | $62.60 | $76.07 |
| Indicator | OVV | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 69.09 |
| Support Level | $37.18 | $75.10 |
| Resistance Level | $62.60 | N/A |
| Average True Range (ATR) | 1.76 | 0.19 |
| MACD | -0.85 | 0.03 |
| Stochastic Oscillator | 16.69 | 95.19 |
Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.